|
|
Solid Phase Extraction
MIP Technologies Products Cross Reference
|
|
|
| MIP Technologies |
|
Supelco |
| Cat. No. |
Product Name |
|
Cat. No. |
Product Name |
Description |
| 1001-0025-G |
MIP[4]SPE Clenbuterol |
|
53201-U |
SupelMIP SPE Clenbuterol |
25mg/10mL (LRC), pk 50 |
| 1002-0025-G |
MIP[4]SPE Beta-agonist |
|
53202-U |
SupelMIP SPE Beta-agonist |
25mg/10mL (LRC), pk 50 |
| 1002-0025-B |
MIP[4]SPE Beta-agonist |
|
53225-U |
SupelMIP SPE Beta-agonist |
25mg/3mL, pk 50 |
| 1003-0025-B |
MIP[4]SPE NNAL |
|
53203-U |
SupelMIP SPE NNAL |
25mg/3mL, pk 50 |
| 1003-0025-G |
MIP[4]SPE NNAL |
|
53206-U |
SupelMIP SPE NNAL |
25mg/10mL (LRC), pk 50 |
| 1004-0025-G |
MIP[4]SPE Riboflavin (Vitamin B2) |
|
53207-U |
SupelMIP SPE Riboflavin (Vitamin B2) |
25mg/10mL (LRC), pk 50 |
| 1005-0025-G |
MIP[4]SPE Triazine 10 |
|
53208-U |
SupelMIP SPE Triazine 10 |
0 25mg/10mL (LRC), pk 50 |
| 1006-0025-B |
MIP[4]SPE Chloramphenicol |
|
53209-U |
SupelMIP SPE Chloramphenicol |
25mg/3mL, pk 50 |
| 1006-0025-G |
MIP[4]SPE Chloramphenicol |
|
53210-U |
SupelMIP SPE Chloramphenicol |
25mg/10mL (LRC), pk 50 |
| 1007-0025-B |
MIP[4]SPE Beta-Blocker |
|
53213-U |
SupelMIP SPE Beta-Blocker |
25mg/3mL, pk 50 |
| 1007-0025-G |
MIP[4]SPE Beta-Blocker |
|
53218-U |
SupelMIP SPE Beta-Blocker |
25mg/10mL (LRC), pk 50 |
| 1008-0025-G |
MIP[4]SPE TSNAs |
|
53221-U |
SupelMIP SPE TSNAs |
50mg/10mL (LRC), pk 50 |
| 1008-0025-B |
MIP[4]SPE TSNAs |
|
53222-U |
SupelMIP SPE TSNAs |
50mg/3mL, pk 50 |
| 1009-0025-G |
MIP[4]SPE Beta receptor |
|
53223-U |
SupelMIP SPE Beta-Receptors |
25mg/10mL (LRC), pk 50 |
| 1009-0025-B |
MIP[4]SPE Beta receptor |
|
53224-U |
SupelMIP SPE Beta-Receptors |
25mg/3mL, pk 50 |
|
|